Intro
Fecundity is the individual’s biologic capacity to reproduce irrespective of
pregnancy intentions ( Smarr et
al. , 2017 ). Time to pregnancy (TTP), defined by the time it
takes for a couple to conceive when practicing unprotected intercourse, is a measure
of fecundity, and the final common path of many biologic mechanisms in both sexes
including semen quality and ovulation. TTP is a sensitive measure of fecundity in
both women and men and is generally well recalled ( Zielhuis et al. , 1992 ; Joffe et al. , 1995 ),
with a shorter TTP indicating a higher fecundity ( Christensen et al. , 1998 ). About
15% of couples take more than 12 months to conceive (i.e. clinical
infertility; Del Giudice et
al. , 2020a ), and it has been suggested that semen quality
and fecundity have declined over recent decades ( Carlsen et al. , 1992 ; Smarr et al. , 2017 ).
The reasons for this decline are largely unknown, but may include lifestyle and
behavioural factors as well as exposure to environmental chemicals ( Sharma et al. , 2013 ;
Skakkebaek et al. ,
2016 ; Kim et
al. , 2019 ). A recent Danish twin study found that environmental
factors specific for each twin explained around 70% of the subfecundity
(defined as a TTP > 10 months) in women and 95% of that in
men. The relative contribution of additive genetic factors to TTP was around
30% in women and 5% in men ( Ahrenfeldt et al. , 2020 ).
There is growing evidence that women with an infertility diagnosis may be predisposed
to develop health problems ( Hanson
et al. , 2017 ). Several diseases have been linked to
female subfecundity including obesity, type 2 diabetes mellitus, cardiovascular
disease and polycystic ovarian syndrome (PCOS; Teede et al. , 2010 ; Flegal et al. , 2012 ;
Tobias et al. ,
2015 ; Hanson et
al. , 2017 ). Particularly, the health implications of PCOS
have been thoroughly documented, and the findings include an increased risk of lower
quality of life and higher risks of mental health challenges, diabetes,
cardiovascular disease, hypertension and metabolic syndrome ( Hallajzadeh et al. , 2018 ; Amiri et al. , 2020 ;
Osibogun et al., 2020 ; Thong et al., 2020 ; Wilson and Peña, 2020 ; Yin et al., 2021 ). Other retrospective
cohort studies based on insurance claims data have demonstrated that infertile women
(women with an infertility diagnosis, women receiving fertility testing or fertility
treatment) are at higher risk of cancer and incident chronic medical disease ( Murugappan et al. ,
2019a,b ). They are also more likely to develop diabetes, renal, liver and
heart diseases, cerebrovascular disease and drug abuse compared with non-infertile
women, suggesting that infertility and subfecundity in women may reflect a window to
overall health ( Murugappan et
al. , 2019a ).
Studies in men from Europe and the U.S. have found associations between semen quality
and subsequent morbidity ( Jacobsen
et al. , 2000 ; Eisenberg et al. , 2013 , 2015b, 2016 ; Latif et al. , 2017 ; Latif et al. , 2018 ;
Ferlin et al. ,
2019 ) and mortality ( Jensen
et al. , 2009 ; Eisenberg et al. , 2014 ; Glazer et al. , 2019 ).
A Danish retrospective cohort study followed 43 277 men, who were referred for semen
analysis due to fecundity problems, for 40 years and found a
dose–response relationship between good semen quality and reduced mortality.
Interestingly, the increased mortality associated with poor semen quality was due to
a wide variety of diseases not only linked to diseases associated with poor
socioeconomic status ( Jensen et
al. , 2009 ). Another Danish cohort study followed 4712 men
referred for possible infertility from 1977 to 2010 in the national hospitalization
register, and found that men with poor semen quality had a higher mortality and
hospitalization rate particularly from cardiovascular diseases and diabetes compared
to men with good semen quality ( Latif
et al. , 2017 ). An American study including 13 027
men diagnosed with male factor infertility found that having an infertility
diagnosis increased the risk of developing diabetes and ischemic heart disease by
30% and 48%, respectively ( Eisenberg et al. , 2016 ).
Here we use data from two large cohorts of Danish twins (born 1931–1952 and
1953–1976) to shed light on potential health consequences of reduced
fecundity. Although this study does not explicitly use a twin design, these twin
cohorts include detailed information on TTP and are linked to high-quality Danish
registry data. Thus, by using the Danish twins, we specifically aim to investigate
the associations between self-reported time to first pregnancy and subsequent
mortality and hospitalizations. We hypothesize that reduced fecundity is associated
with higher mortality and hospitalization rates.
Results
A total of 1305 (9.3%) deaths of all causes were observed in 14 104 twins
during the 24-year follow-up period; 608 (7.8%) women and 697
(11.1%) men. More deaths were observed in the MADT sample (women: 362
(20.2%), men: 465 (26.8%)) than in the Omnibus sample (women: 246
(4.1%), men: 232 (5.1%); Table I ). Hospitalization rates were 177/1000 person-years for women
and 180/1000 person-years for men. The Omnibus sample contributed with more
hospitalizations than the MADT sample, although the hospitalizations rates were
highest in the MADT ( Table I ). A
total of 49.9% of women and 52.7% of men reported a TTP <
2 months. Of these, 274 (7.1%) women and 330 (10.0%) men
died. A total of 30.8% of women and 29.6% of men reported a TTP of
2–9 months. Of these, 191 (7.9%) women and 224
(12.1%) men died. A total of 6.6% of women and 5.7% of men
reported a TTP of 10–17 months. Of these, 42 (8.2%) women
and 55 (15.4%) men died. A total of 13.3% of women and
12.0% of men reported a TTP of ≥ 18 months. Of these, 101
(9.7%) women and 88 (11.7%) men died. Study participants were on
average 39.4 years at interview (56.8 years in the MADT and
33.7 years in the Omnibus; Table
I ).
Baseline characteristics of 7825 women and 6279 men participating in two
Danish twin surveys between 1931 and 1976.
Data are n (%) unless stated otherwise. Percentages are
calculated without missing values.
IQR: interquartile range.
Between interview (February to December 1998 for twins born
1931–1952 and December 31, 1994 for twins born
1953–1976) and end of follow-up (March 18, 2018).
The combined results showed an indication of a higher mortality among women
reporting a TTP of 2–9 months (HR = 1.06; 95% CI
0.88, 1.28) and 10–17 months (HR = 1.09; 95% CI
0.78, 1.52), and a significantly higher mortality among women reporting a TTP
≥ 18 months (HR = 1.46; 95% CI 1.15, 1.87), which
remained significant after adjusting for multiple testing ( Table II ). A significant
dose–response relationship was found for women
( P = 0.022). For men, an indication was
found towards higher mortality for those reporting a TTP of
10–17 months (HR = 1.31; 95% CI 0.98, 1.74) and
≥18 months (HR = 1.24; 95% CI 0.97, 1.59) compared
with those reporting a TTP of <2 months ( Table II ). When investigating the associations for
the MADT and the Omnibus separately, we found similar patterns with higher
mortality among women reporting a TTP of ≥18 months, and a
significant dose–response relationship in Omnibus women
( P = 0.026; Table II ). Among the seven causes of death, we found
an increased risk of death among women reporting a TTP of
≥18 months for pneumonia and other respiratory diseases (SHR
= 2.30; 95% CI 1.04, 5.12) and an even stronger association with
digestive, urinary, genital and endocrine diseases (HR = 3.49; 95%
CI 1.58, 7.72), with the latter remaining significant after adjusting for
multiple testing. In men, only the association with ill-defined conditions,
senility, unknown cause and other diseases in the TTP group of
10–17 months was significant (HR = 2.37; 95% CI
1.20, 4.69; Table III ).
Hazard ratios (HRs) and incidence rate ratios (IRRs) for mortality and
hospitalizations among Danish women and men born 1931–1976 with
a time to pregnancy (TTP) of 2–9, 10–17 and
18 months or more relative to those with a TTP of less than
2 months.
All results are adjusted for birth cohort, age at first attempt to
become pregnant, smoking, years in school and BMI.
Significant after adjusting for multiple testing.
HR: Hazard ratio, IRR: Incidence rate ratio, CI: confidence
interval.
Number of observations for mortality: Women (MADT: 1777, Omnibus:
5758; Combined: 7535). Men: (MADT: 1726, Omnibus: 4356; Combined:
6082). Note. Each participant can contribute with more than one
hospitalization. Number of observations for hospitalizations are
stated in Table
I .
Cause-specific sub hazard ratios (SHR) for Danish women and men born
1931–1976 with a time to pregnancy (TTP) of 2–9,
10–17 and 18 months or more relative to those with a TTP
of less than 2 months, while considering competing risks from
the other causes of death.
All results are investigated for MADT and Omnibus combined and are
adjusted for birth cohort, age at first attempt to become pregnant,
smoking, years in school and BMI.
Significant after adjusting for multiple testing.
SHR: Sub hazard ratio, CI: Confidence interval.
- Model convergence was not achieved due to low counts, and it was
hence not possible to run the model and gain results for pneumonia
and other respiratory disease among men.
For the combined sample, we found a dose–response relationship in women
( P = 0.018) with the highest
hospitalization rate (IRR = 1.21; 95% CI 1.04, 1.41) among those
with a TTP of ≥ 18 months, and this remained significant after
adjusting for multiple testing ( Table
II ). A similar pattern was found in the MADT, with more
hospitalizations in women reporting a TTP of ≥ 18 months (IRR
= 1.46; 95% CI 1.11, 1.93). A dose-response relationship was found
for the Omnibus ( P = 0.044), but with
non-significant associations ( Table
II ). In the combined sample, we found an increased risk of
hospitalizations in men reporting a TTP of 2–9 months (IRR
= 1.14; 95% CI 1.01, 1.30) and of ≥18 months (IRR
= 1.16; 95% CI 1.00, 1.35). A similar pattern was found in the
Omnibus ( Table II ). When
investigating the specific hospitalizations, we found more hospitalizations from
nutritional and metabolic diseases in women with a TTP of
2–9 months (IRR = 1.54; 95% CI 1.16, 2.05) and of
≥18 months (IRR = 1.69; 95% CI 1.11, 2.57). In
addition, women with a TTP of ≥18 months had an increased risk
of hospitalization for diseases of the respiratory organs (IRR = 1.38;
95% CI 1.04, 1.84), of the musculoskeletal system and connective tissue
(IRR = 1.29; 95% CI 1.05, 1.69), and for symptoms, signs and
ill-defined conditions (IRR = 1.17; 95% CI 1.01, 1.35). Men with a
TTP of ≥18 months had more hospitalizations for infectious and
parasitic diseases (IRR = 1.66; 95% CI 1.08, 1.52), diseases of
the genito-urinary system (IRR = 1.52; 95% CI 1.01, 1.29) and
diseases of the skin and subcutaneous tissue (IRR = 1.85; 95% CI
1.02, 1.35) as well as for mental disorders (IRR = 2.14; 95% CI
1.21, 3.78), where a dose–response relationship was found
( P = 0.019; Table IV ). When investigating diabetes separately,
we found more hospitalizations among women with a TTP of
2–9 months (IRR = 3.06; 95% CI 1.25, 7.49) and
≥18 months (IRR = 10.5; 95% CI 2.75, 40.0),
whereas for men, fewer hospitalizations were found in the
2–9 months group (IRR = 0.41; 95% CI 0.21, 0.78;
results not shown in table). Few associations were significant after adjusting
for multiple testing ( Table
IV ).
Cause-specific incidence rate ratios (IRRs) for hospitalizations among
Danish women and men born 1931–1976 with a time to pregnancy
(TTP) of 2–9, 10–17 and 18 months or more
relative to those with a TTP of less than 2 months.
All results are investigated for the MADT and the Omnibus combined
and are adjusted for age at interview, birth cohort, age at first
attempt to become pregnant, smoking, years in school and BMI.
Significant after adjusting for multiple testing.
Note: Each participant can contribute with more than one
hospitalization.
Overall, the crude and the adjusted analyses were similar ( Supplementary Table SV ).
When we included all the twins who became pregnant despite the use of
contraception in the lowest TTP group (<2 months), the results
were similar to the overall results ( Supplementary Table SVI ). When investigating the
association with mortality among the youngest twins (censored at age
45 years), the overall results were like the main results ( Supplementary Table
SVII ). After adjusting for diseases related to pregnancy in the MADT
sample, we found overall the same results as in the main analysis, with higher
mortality and more hospitalizations among women with a TTP of
≥18 months, although the association with mortality became
borderline significant ( Supplementary Table SVIII ). No significant differences were found
when comparing mortality among individuals who tried to become pregnant and
those who never tried to become pregnant, but a tendency towards higher
mortality among those who never tried were found both among women (HR =
1.44; 95% CI 0.96, 2.14) and among men (HR = 1.41; 95% CI
0.96, 2.06). No differences were found among those who tried to become pregnant
and those with missing data on TTP ( Supplementary Table SIX ).
Materials
The present longitudinal study is based on two Danish nationwide twin cohorts.
The Omnibus survey ( Kyvik et
al. , 1995 ) was conducted in 1994 (between February and
December) and included all twins born in 1953–1982, who were identified
in the Danish Twin Registry ( Skytthe
et al. , 2011 ; Pedersen et al. , 2019 ). The
response rate of the health-related questionnaire survey was 89%, which
corresponded to 79% of the Danish twin population ( Christensen et al. , 1998 ). The
Middle-Aged Danish Twin study (MADT) was initiated between 1996 and 1998 by a
random selection of 2640 twin pairs born 1931–1952 from the Danish
Central Person Registry ( Gaist
et al. , 2000 ).
The current study focuses on respondents who participated in one of the twin
surveys, were 18 years or older at survey intake (restricting the study
population to the 1931–1976 birth cohorts), and had measures on TTP. We
excluded 6282 twins who had never tried to become pregnant and 8226 twins with
missing data on TTP, resulting in a study population of 14 104 twins (3533 twins
from the MADT survey and 10,571 twins from the Omnibus survey; Supplementary Fig.
S1 ).
The Danish Twin Registry was linked to national health registers through a unique
personal identification number (a CPR number) assigned to all persons alive and
living in Denmark from 2 April 1968 and onwards. This unique CPR number enables
linkage at the individual level between Danish nationwide administrative
registers and other data sources ( Thygesen et al. , 2011 ). We used the Danish Civil
Registration System ( Pedersen,
2011 ) for information on mortality (from 1968), the Causes of Death
Registry for information on death causes ( Helweg-Larsen, 2011 ; from 1970) and the National
Patient Register ( Schmidt et
al. , 2015 ) for information on hospitalizations (from
1977). Causes of death were grouped according to a 49-item list from the Causes
of Death Registry ( Helweg-Larsen,
2011 ). This list contains 49 causes of death based on the
‘International Classification of Diseases’ (ICD8 before 1993 and
ICD10 from 1994 and onwards; eSundhed,
2020 ). In this study, the causes of death were further reduced to
seven groups due to small numbers in some categories. Cause-specific
hospitalizations were based on a grouping of 99 diagnoses, further combined into
13 main groups defined by Statistics Denmark ( Statistic Denmark, 2020 ). The corresponding ICD-10
codes are provided in Supplementary Tables SI and SII .
In both the MADT and the Omnibus survey data were collected on waiting time to
first pregnancy. In the MADT, the question was: ‘How many years and
months did it take before you became pregnant?’ In the MADT sample,
questions regarding the first pregnancy concerned only pregnancies that did not
end in an abortion or an extrauterine pregnancy. Thus, the questions in the MADT
only applied to those who gave birth to one living child, to twins or triplets,
or to one stillborn child. In the Omnibus, the question was: ‘What year
did you and your partner try to have children for the first time?’
‘How did this first try end?’. The question was based on the
following categories: ‘never tried to become pregnant’,
‘became pregnant despite contraception’, ‘became
pregnant after × months’, ‘stopped trying after ×
months’, ‘still trying and have now been trying for ×
months’. Answer categories were as follows: <2, 2–4,
5–9, 10–17 and ≥18 months. We combined the
answer categories for people who became pregnant, those who stopped trying and
those who were still trying. The distribution of TTP in the three groups can be
found in Supplementary Table
SIII , and the distribution of TTP in the total study population can
be found in Supplementary
Table SIV .
Covariates included age at first attempt to become pregnant based on calendar
year, which in the MADT was the year when pregnancy number one ended, and in the
Omnibus it was the year when the couple was trying to have children for the
first time. Age was divided into four groups: less than 21 years,
21–25 years, 26–30 years and 31 years
and above. Birth cohorts were divided into 5-year groups between 1931 and 1976.
In the MADT survey, smoking was assessed by the question: ‘At present,
do you smoke?’ The yes category included the answers: ‘Yes, more
than 1 cigarette, cheroot or 1 pipe of tobacco a day’ and
‘yes, but less than 1 cigarette, cheroot or 1 pipe of tobacco a
day’. In the Omnibus, smoking was based on the question: ‘Do you
smoke?’ which included three categories: ‘no’,
‘yes, daily’, ‘yes, but not every day’. We
combined these categories into yes (daily and almost every day) and no. Years in
school were grouped into 7 years or less, 8–10 years and
11 years or more. Body mass index (BMI) was based on self-reported
measures on height and weight (weight (kg)/height (m 2 )).
TTP was restricted to the first pregnancy and investigated among women and men
with a TTP of 2–9, 10–17 and 18 months or more, relative
to those with a TTP of less than 2 months (all cut-points were chosen
based on the answer categories in the Omnibus). We pooled twins independently of
zygosity, because a previous study on the Danish twins found no substantial
evidence that fecundity of female twins is different according to zygosity or
sex of the co-twin ( Christensen
et al. , 1998 ). The subgroup of individuals who
conceive without trying is difficult to classify regarding fecundity, as this
group may include both individuals who use irregular and/or less effective
contraception and individuals with high fecundity ( Christensen et al. , 1998 ). In the
main analysis, we included individuals who conceived without trying if they
reported a TTP. We classified them into the groups that corresponded to their
reported TTP, but excluded them if they did not report a TTP (i.e. if TTP was
missing).
The overall analyses were performed for both the MADT and the Omnibus separately
and for the combined sample. Due to small samples in some of the subgroups,
analyses of causes of death and hospitalizations were done for the combined
sample alone. All analyses were stratified by sex and adjusted for birth cohort,
age at first attempt to become pregnant, smoking status, years in school and
BMI. In all regression analyses, we took the twin structure of the data into
account by using robust standard errors clustered on the twin pair.
Time to event analyses were used, with age as the time scale, to investigate
mortality by TTP. Using a Cox proportional hazards analysis, we estimated hazard
ratios (HRs) with 95% confidence intervals (CIs) for all-cause mortality.
In addition, we estimated sub-hazard ratios (SHRs) applying a Fine-Gray
competing risk model ( Fine and Gray,
1999 ) with the seven different causes of death as events, taking
competing risk from the other death causes into account. The Cox proportional
hazards assumption was verified using the log-log plot of the
Kaplan–Meier survival function as well as the by Schoenfeld residuals,
and all assumptions were met.
Hospitalization was measured as admission to a hospital for any reason as an
inpatient. Due to sign of overdispersion, negative binomial regression was used
to estimate frequency of hospitalizations calculating incidence rate ratios
(IRRs) with 95% CIs. Also, we investigated cause-specific
hospitalizations for the 13 different diagnosis groups and for diabetes
separately. Follow-up started at interview and continued until death, emigration
or end of follow-up (16 March 2018), whichever came first.
To investigate the robustness of the results, we performed several sensitivity
analyses. First, we repeated the main analysis unadjusted, but with age as the
underlying time scale, for mortality and adjusted only for age at interview in
5-year groups for hospitalizations ( Supplementary Table SV ). Second, we included all
individuals who reported becoming pregnant despite the use of contraception in
the lowest TTP group (<2 months), also those who were excluded
from the main analysis due to missing TTP ( Supplementary Table
SVI ). Third, to investigate the associations among the youngest
participants only, we made a sensitivity analysis in which all individuals were
censored at age 45 years ( Supplementary Table SVII ). Fourth, in the MADT sample,
where information was available, we repeated the main analysis further adjusting
for diseases related to pregnancy as a binary variable (yes/no). Among women,
the ‘yes’ category was given to those who answered
‘yes’ to at least one of the following questions: ‘Have
you had any diseases or problems which made it difficult for you to become
pregnant?’ ‘Have you ever had an operation, which made it
difficult for you to become pregnant?’ ‘Did a doctor ever tell
you that you suffered from one of the following diseases?’: pelvic
infection, salpingitis, cyst on the ovaries, chlamydia infection, gonorrhoea,
endometriosis and appendicitis with burst appendix. Similarly, a binary variable
was constructed for men, with the ‘yes’ category including men,
who reported ‘no’ to the question: ‘Are both your
testicles in your scrotum?’ or reported ‘yes’ to both
questions: ‘Did you have mumps during adulthood?’ ‘Were
your testicles affected?’ or who reported ‘yes’ to the
question: ‘Have you ever had an operation for inguinal hernia,
varicocele or a disease in the scrotum, penis or urethra?’ ( Supplementary Table
SVIII ). Lastly, we investigated mortality risks among twins who tried
to become pregnant (women and men in the study population) relative to those who
never tried to become pregnant and those with missing data on TTP (the latter
two groups were excluded from the analyses; Supplementary Table
SIX ).
All main results were corrected for multiple testing by the
Holm–Bonferroni method ( Holm,
1979 ), which was done in R (version 3.6.1). The statistical software
Stata (version 16.0) was used for all other analyses.
Discussion
In this large prospective, population-based twin cohort study, reduced fecundity was
associated with increased morbidity and mortality and may therefore be a general
marker of health and survival. A TTP of 18 months or more was associated
with increased mortality in women and with increased hospitalization rates in both
sexes. The cause-specific mortality and hospitalization diagnoses suggested that
impaired fecundity was associated with a wide range of diseases and causes of
deaths, including hospitalizations and causes of death not directly linked to the
reproductive tract, such as respiratory diseases in women (mortality and
hospitalizations) and mental disorders for men (hospitalizations). This indicates a
multi-factorial causal influence on fecundity, especially among women.
Previous studies have reported an association between female infertility (defined as
having tried to become pregnant for more than 1 year without success) and increased
risk of cardiovascular disease and diabetes ( Farland et al. , 2015 ; Tobias et al. , 2015 ; Mahalingaiah et al. ,
2017 ); however, we did not find any increased mortality risk of ischemic
heart disease and other cardiovascular disease in women with impaired fecundity, nor
did we find any increased risk of hospitalizations for diseases of the circulatory
system. Diabetes was included in the category nutritional and metabolic diseases,
and we found an 54% increased hospitalization risk among women reporting a
TTP of 2–9 months and a 69% increased risk among those
reporting a TTP of ≥ 18 months. When investigating diabetes
separately, we found an even stronger association between TTP and hospitalizations
for women, supporting the indication of metabolic syndrome (e.g. higher body mass
index and PCOS) as a source of impaired fecundity ( Abraham et al. , 2021 , Lainez and Coss, 2019 ). The higher
mortality and hospitalization rates from respiratory diseases in women could
potentially be a marker of an association with smoking ( Bolumar et al. , 1996 ; Sapra et al. , 2016 );
however, in the present study, adjusting for current smoking did not influence the
overall results.
Our findings of increased morbidity among men with long TTP are parallel to previous
work using semen quality as a measure of fecundity ( Jacobsen et al. , 2000 ; Eisenberg et al. ,
2013 , 2015b, 2016 ; Latif et al. , 2017 ;
Latif et al. ,
2018 ; Ferlin et
al. , 2019 ). Moreover, our findings are in line with results
from a recent review suggesting an association between male factor infertility and
somatic health ( Del Giudice et
al. , 2020b ). The review suggested that infertile men appear
to be at a higher risk of chronic disease regardless of socio-demographic factors,
and that the literature is consistent in demonstrating higher risk of cardiovascular
disease in men with impaired fertility ( Del
Giudice et al. , 2020b ). We did find significant
associations with overall hospitalizations in men, and we found that a prolonged TTP
in men was associated with more hospitalizations for mental disorders, diseases of
the respiratory organs, infectious and parasitic diseases, disease of the
genito-urinary system and diseases of the skin and subcutaneous tissue.
Interestingly, we found no increased risk of any specific cause of death among men
with impaired fecundity except for a higher risk of death from unknown and other
causes. This was in line with results reported by Jensen et al. ,
who did not find an increased risk for any specific cause of death among men with
impaired semen quality ( Jensen et
al. , 2009 ).
The association between impaired fecundity and the risk of developing a malignancy is
an ongoing concern ( Murugappan et
al. , 2019b ). In the literature, the association between male
infertility and cancer varies dependent on the specific cancer examined, and results
are conflicting ( Del Giudice et
al. , 2020b ). However, studies suggest that infertile women
have a higher risk of certain cancers, particularly hormone-related cancers of the
breast, ovaries and endometrium, than women from the general population ( Murugappan et al. ,
2019b ), and that men with impaired fecundity have a higher risk of
testicular and prostate cancer ( Del Giudice
et al. , 2020a ). In this study, we found no
significant associations with cancer, but indications were found towards higher
mortality and more hospitalizations for cancer among women with a TTP
≥18 months.
In the present study, we found the different organ systems of diseases and causes of
death to be markers of fecundity in Danish twins, which supports the previous
extensive literature on a complicated, interrelated causality for impaired fecundity
in many contemporary human populations. The link among fecundity, mortality and
morbidity could be due to genetic, hormonal, lifestyle or in utero
factors ( Barker, 2004 ; Araujo et al. , 2011 ;
Sharma et al. ,
2013 ; Choy and Eisenberg,
2018 ; Ahrenfeldt et
al. , 2020 ). Low testosterone and oestradiol levels have been
associated with low semen quality and fewer ovulations, and with subsequent
morbidity and mortality ( Haring et
al. , 2010 ; Araujo
et al. , 2011 ; Chock et al. , 2012 ; Grin et al. , 2020 ). Nevertheless, the
association between fecundity and subsequent health may be confounded by current
health and lifestyle ( Latif et
al. , 2017 ). For example, obesity and smoking are known to
adversely affect ovulation, semen parameters, health and life expectancy ( Jensen et al. , 2004 ;
Ramlau-Hansen et al. ,
2007 ; Whitlock et
al. , 2009 ; Eisenberg
et al. , 2015a ; Sapra et al. , 2016 ; Lainez and Coss, 2019 ; Snider and Wood, 2019 ; Chudasama et al. ,
2020 ; de Angelis et
al. , 2020 ). In addition, semen quality and the number of
oocytes may be determined in utero and exposure to smoking in utero
has been associated with reduced fecundity in both sexes ( Ramlau-Hansen et al. , 2007 ; Fowler et al. ,
2014 ).
To our knowledge, this is the first longitudinal study investigating associations
between time to pregnancy and subsequent health. The main strength of this study was
the population-based surveys of Danish twins linked at the individual level to
several Danish registries, with complete information on mortality and hospital
admissions with up to 24 years of follow-up. Because in-vitro fertilization
treatment was not performed before the 1980s in Denmark, it has not affected our
results. However, limitations also need mentioning. We combined two slightly
different survey studies, which may have influenced the results. The MADT and the
Omnibus surveys contributed 25% and 75% of the study population,
respectively; however, because the MADT sample consists of the oldest birth cohorts,
a higher proportion died during the study period (23.1%) compared with the
Omnibus sample (4.5%), whereas the Omnibus survey contributed most to the
hospitalization results. Compared with the Omnibus, the MADT survey was more
restrictive in the pregnancies that were included (no extra-uterine pregnancies or
pregnancies that ended in an abortion were included). Thus, a prolonged TTP in the
Omnibus may be more discerning than a prolonged TTP in the MADT. The strong
association between TTP and mortality in Omnibus women, also when we censored all
persons at age 45 years, may indicate that premature mortality is also an
outcome of concern in relation to TTP, which should be further investigated in
future research.
Another methodological point is that the study population was conditioned on survival
until interview. If impaired fecundity increases mortality (for which the evidence
both from this and from previous studies is quite strong), then there will be
differential survival across fecundity groups, which can bias outcomes. In this
case, where we condition on survival until interview, we would expect an
underestimation of the investigated associations (i.e. bias towards the null). Our
results would, thus, underestimate the true effect, which may be even more
pronounced among men than among women. Due to the higher mortality rate for males
than females, surviving men are likely to be more physically robust ( Austad and Fischer, 2016 ). Thus, if the
weakest men especially those with long TTP died before interview, this may explain
some of the null findings among men.
Another limitation in this study is that fecundity depends on both partners, which
was not considered, because we had only information about the twins (i.e. not on
their partners). Although TTP is a sensitive measure of fecundity and has been shown
to be well recalled, men recall it less reliably than women, and the recall
deteriorates with age ( Joffe, 1989 ).
Thus, results may be more uncertain in the MADT, where participants should remember
their TTP for up to 49 years compared with the Omnibus, where TTP should be
remembered for up to 25 years. Also, the reporting may be less reliable for
men than for women, which may, at least to some degree, explain the non-significant
findings regarding mortality in men. Moreover, there are potential confounders that
we were not able to consider, such as lifestyle factors, behaviour, socioeconomic
status, maternal diethylstilbestrol (DES) use during pregnancy (which may be
relevant to a subset of the study population) and, for women, conditions such as
menstrual irregularity, PCOS and/or endometriosis, which would have been ideal to
take into account for the entire population and not only for the MADT sample.
Moreover, current smoking and BMI were measured at interview and not around the time
of the first attempt to become pregnancy, which may have influenced our results.
Nevertheless, adjusting for diseases related to pregnancy in the MADT sample did not
change the overall results, and the unadjusted and the adjusted results were similar
overall, pointing towards robust findings.
Another limitation may be the generalizability of our findings. There are at least
two potential confounders common to twin pregnancies that may be linked both to
fecundity and to later morbidity/mortality: first, whether the twins are born small
for gestational age, and, second, whether their mothers used drugs for ovarian
stimulation to become pregnant. A previous study based on the Omnibus sample
evaluated whether female twins from opposite-sex twin pairs have reduced fecundity
compared with other female twins, and whether fecundity differs between twins and
singletons. The study demonstrated similar distribution of waiting time to first
pregnancy independent of zygosity (i.e. monozygotic, same-sex dizygotic and
opposite-sex twins), and they found no increase in fecundity for female twins
compared with singleton females, except that more twins had a TTP of less than 2
months, which was expected to be an artifact due to the data collection method. No
differences were found between twins and singletons for longer waiting times ( Christensen et al. ,
1998 ). Furthermore, few twins in this study are born after the 1960s,
where drugs for ovarian stimulation were introduced in Denmark ( Mosgaard et al. , 1995 )
and, thus, it is unlikely that the potential use of these drugs has influenced the
fecundity of the study population. Nevertheless, we do not know the proportion of
same-sex couples in this study, and whether these proportions are representative for
the general population. Sexual orientation may be influenced by, for example,
in utero endocrine disruption ( Hines, 2011 ), which could also affect fecundity and
morbidity/mortality. This may restrict the generalizability of our results.
Moreover, this study includes only those who have tried to become pregnant, which
may suggest another potential limitation of the generalizability of the results.
Another important limitation was the low number of cases in some subgroups of deaths
and hospitalizations and the low number of individuals particularly in the TTP group
of 10–17 months; nevertheless, despite the low numbers in some of
the categories, we found a broad spectrum of associations with hospitalizations for
several different diseases supporting the notion that fertility status could be used
as an early surrogate of overall health.
In conclusion, in these large twin populations, we found an association between
impaired fecundity and subsequent mortality for women and hospitalizations for both
sexes. The broad diversity of cause-specific deaths and hospitalization diagnoses
lends support for a complicated causality pattern acting on the human reproductive
system. Fecundity status is, therefore, likely to be a universal marker of general
health in both women and men; however, our findings need confirmation before they
can be used in clinical settings to identify high-risk groups. In addition, the
mechanism by which fecundity affects subsequent health needs elucidation.
Data Availability
Data underlying this article cannot be shared publicly due to the rules of the Danish
Data Protection Agency.
Supplementary Material
Click here for additional data file.
Click here for additional data file.
Click here for additional data file.
Click here for additional data file.
Click here for additional data file.
Click here for additional data file.
Click here for additional data file.
Click here for additional data file.
Click here for additional data file.
Click here for additional data file.
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.